↓ Skip to main content

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
4 news outlets
blogs
1 blog
twitter
25 tweeters
patent
1 patent

Citations

dimensions_citation
340 Dimensions

Readers on

mendeley
300 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Published in
Journal for Immunotherapy of Cancer, October 2019
DOI 10.1186/s40425-019-0768-9
Pubmed ID
Authors

Andrew A. Davis, Vaibhav G. Patel

Twitter Demographics

The data shown below were collected from the profiles of 25 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 300 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 300 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 45 15%
Student > Master 42 14%
Student > Ph. D. Student 41 14%
Student > Bachelor 30 10%
Other 22 7%
Other 41 14%
Unknown 79 26%
Readers by discipline Count As %
Medicine and Dentistry 79 26%
Biochemistry, Genetics and Molecular Biology 53 18%
Immunology and Microbiology 19 6%
Pharmacology, Toxicology and Pharmaceutical Science 17 6%
Agricultural and Biological Sciences 16 5%
Other 32 11%
Unknown 84 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 48. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2022.
All research outputs
#668,550
of 21,321,610 outputs
Outputs from Journal for Immunotherapy of Cancer
#154
of 2,584 outputs
Outputs of similar age
#19,331
of 350,692 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#20
of 344 outputs
Altmetric has tracked 21,321,610 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,584 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,692 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 344 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.